Clinical Trials Directory

Trials / Sponsors / Effector Therapeutics

Effector Therapeutics

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
CompletedIntravenous Zotatifin in Adults With Mild or Moderate COVID-19
Corona Virus Infection
Phase 12021-07-01
Active Not RecruitingTomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)
Non-small Cell Lung Cancer
Phase 22021-06-02
RecruitingStudy of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Solid Tumor, Adult
Phase 1 / Phase 22019-10-25
TerminatedAn Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prosta
Castrate-resistant Prostate Cancer (CRPC)
Phase 22018-11-27
CompletedTomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy
Solid Tumors
Phase 22018-07-25
TerminatedA PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC
Triple Negative Breast Cancer, Hepatocellular Carcinoma
Phase 22017-11-21
CompletedA Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer
Microsatellite Stable Relapsed or Refractory Colorectal Cancer
Phase 22017-09-18
TerminatedA Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematol
Lymphoma
Phase 1 / Phase 22017-02-08
TerminatedA Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors
Cancer
Phase 1 / Phase 22015-12-03